The article discusses the impact of Roux-en-Y gastric bypass (RYGB) surgery on the remission of type 2 diabetes (T2D) 5 years after the operation. The study found that RYGB was more effective in preventing T2D recurrence compared to sleeve gastrectomy (SG), even after patients regained weight. The research was a retrospective review of patients with a baseline body mass index (BMI) ≥ 35 and preoperative diagnosis of T2D who underwent RYGB or SG, with the RYGB group showing significantly higher rates of continued T2D remission. The study emphasized the potential role of the proximal small intestines in metabolic control independent of weight loss and was published in the Journal of the American College of Surgeons.
Source link
Gastric Bypass Boosts T2D Remission, Even With Weight Regain
